- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06271954
The Relationship Between Emotion Regulation and Psychiatric Disorder in Youth
The Relationship Between Emotion Regulation and Psychiatric Disorder in Youth - From a Psychosocial Developmental Aspect.
According to the increasing worldwide prevalence rate of psychiatric disorders in youth, the mental health of youth is becoming more and more important.
Taiwan's Ministry of Health and Welfare reported the clibing suicide rate of youth in past five years and showed the prevention work and related intervention for youth's mental health was noteable. The definition of emotion regulation was "consists of the extrinsic and intrinsic processes responsible for monitoring, evaluating, and modifying emotional reactions, especially their intensive and temporal features, to accomplish one's goals." Emotion regulation strategies including "rumination", "avoidance", "suppression", "Problem-solving", "reappraisal", "acceptance", "social support", and "distraction".
Previous studies had examined the relationship between emotion regulation and mental health in youth; maladaptive emotion regulation would increase the individual's depressive and anxiety symptoms. Carstensen proposed social emotion theory in 1995 Selectivity theory (SST) refers to the need for emotion regulation, which activates Social participation in late adulthood. SST assumes that young people are more interested in social interaction behaviors related to information seeking and building self-concept. characteristics of youth affected by many normative challenges such as adolescence, school transitions, and more complex social Landscape; Adaptive emotion regulation will reduce risk of clinical emotion attacks of illness, especially depression and anxiety.To explore the relationship between emotion regulation and mental health from a psychosocial developmental aspect, we focused on the interaction between individual and environment. Compared with the previous generation, most youths of this generation were participating in social activities and building up interpersonal relationships through the internet, suggesting the internet was an important social context.
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Tzuyu Liu
- Phone Number: 2720 (02)24329292
- Email: tzuyu35@gmail.com
Study Locations
-
-
-
Keelung, Taiwan, 204
- Recruiting
- Chang-Geng Medical Foundation Chang-Geng Memorial Hospital
-
Contact:
- Tzuyu Liu
- Phone Number: 2720 (02)24329292
- Email: tzuyu35@cgmh.org.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The inclusion criteria for the control group are as follows: (1) Understanding the content of the questionnaire. (2) Healthy adolescents aged 15 to less than 18 years and healthy adults aged 18 to 24 years.
The inclusion criteria for the experimental group are:
- Understanding the content of the questionnaire.
- Adolescents aged 15 to less than 18 years and adults aged 18 to 24 years.
- Diagnosed with major depressive disorder, anxiety disorder, attention deficit hyperactivity disorder (ADHD), or adjustment disorder according to DSM-5.
Exclusion Criteria:
The exclusion criteria for the experimental group are diagnoses of:
- organic brain injury
- schizophrenia
- autism spectrum disorder according to DSM-5.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
control
(1) Understanding the content of the questionnaire.
(2) Healthy adolescents aged 15 to less than 18 years and healthy adults aged 18 to 24 years.
|
experimental
(1) Understanding the content of the questionnaire.
(2) Adolescents aged 15 to less than 18 years and adults aged 18 to 24 years.
(3) Diagnosed with major depressive disorder, anxiety disorder, attention deficit hyperactivity disorder (ADHD), or adjustment disorder according to DSM-5.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Difference and Similarity in Emotional Regulation Strategy Patterns between Western and Eastern Countries.
Time Frame: Each respondent interviews and fills out questionnaires, which takes about 20minutes.
|
To examine the cultural difference in emotion regulation strategies, we applied CERQ(Cognitive Emotion Regulation Questionnaire) to measure the cognitive regulation pattern of the Taiwanese and compared it with research articles that reported the CERQ results in six European countries and China. Cognitive Emotion Regulation Questionnaire (CERQ). The CERQ includes nine positive/negative adaptive emotion regulation strategies: self-blame, rumination, Blaming others, catastrophizing, acceptance, positive refocusing, refocus on planning, positive reappraisal, putting into perspective ), each strategy subscale contains 4 questions, a total of 36 questions, and is answered in the form of a five-point scale. Subjects describe each question and circle the options that are consistent with their own situation (never, rarely, sometimes , often, always), each item ranges from 1 "never" to 5 "always", one point per question, no reverse questions. |
Each respondent interviews and fills out questionnaires, which takes about 20minutes.
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Mood Disorders
- Trauma and Stressor Related Disorders
- Attention Deficit and Disruptive Behavior Disorders
- Neurodevelopmental Disorders
- Depressive Disorder
- Problem Behavior
- Anxiety Disorders
- Mental Disorders
- Attention Deficit Disorder with Hyperactivity
- Depressive Disorder, Major
- Adjustment Disorders
Other Study ID Numbers
- 202300096A3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder (ADHD)
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ironshore Pharmaceuticals and Development, IncCompletedAttention-Deficit Hyperactivity Disorder (ADHD)United States
-
Massachusetts General HospitalShireCompletedAttention Deficit/Hyperactivity Disorder(ADHD)United States
-
Medical University of South CarolinaShireCompletedAdult Attention Deficit Hyperactivity Disorder (ADHD)United States
-
Sheba Medical CenterCompletedADHD Predominantly Inattentive Type | Attention Deficit/Hyperactivity Disorder Combined Type | ADHD Predominantly Hyperactivity Type | ADHD-not Other SpecifiedIsrael
-
Cingulate TherapeuticsRho, Inc.CompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder CombinedUnited States
-
Tris Pharma, Inc.Massachusetts General Hospital; Massachusetts Institute of TechnologyCompleted
-
Karolinska InstitutetRegion StockholmCompleted